Tresiba
Product Images NDC 50090-7077

Product Visual Gallery

This gallery contains 63 technical images submitted to the FDA as part of the official labeling for Tresiba (NDC 50090-7077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Structural Formula Of Tresiba (Image 01)

Chemical structure diagram showing the linear sequence and branching of amino acids and a lipid side chain of the active ingredient in TRESIBA, illustrating its molecular composition and peptide chain arrangement.*

FDA Label Image

Figure 2: Mean Gir Profile For 0.4 U/kg Dose Of Tresiba (steady State) In Patients With Type 1 Diabetes Mellitus (Image 02)

A line graph depicting the glucose infusion rate (GIR) over time since injection (hours) for TRESIBA. The x-axis represents time from 0 to 42 hours, with a shaded area indicating the 24-hour interval. The y-axis shows the GIR values, with the treatment labeled as IDeg 0.4 U/kg represented by a blue line, demonstrating changes in GIR following injection.*

FDA Label Image

Vial Ifu-1 (Image 03)

Illustration of a vial with a tamper-resistant cap featuring a rubber stopper under the cap. The diagram highlights the vial's packaging attributes, emphasizing safety and sterility features.*

FDA Label Image

Vial Ifu-2 (Image 04)

An instructional illustration showing a hand holding a vial, likely demonstrating how to hold or handle the vial properly. No text or branding is visible in the image.*

FDA Label Image

Vial Ifu-figure A,b (Image 05)

An instructional illustration showing two steps: a hand holding a capped pen-like device, and then a hand removing or adjusting the cap. This likely depicts how to prepare or use the device, possibly for insulin injection, related to the TRESIBA product.*

FDA Label Image

Vial Ifu-figure C (Image 06)

An instructional illustration demonstrating how to attach a pen needle to an insulin pen device. It shows one hand holding the pen and the other hand aligning and pushing a pen needle onto it for secure attachment.*

FDA Label Image

Vial Ifu-figure D (Image 07)

An instructional illustration showing a hand holding a pen-like device with the other hand pulling off a cap from the device tip, indicated by an arrow pointing away from the device. The image likely demonstrates how to remove the cap before use.*

FDA Label Image

Vial Ifu-figure E (Image 08)

An instructional illustration showing a hand holding a pen-like device angled toward a vial or container with a capped needle attachment. An arrow indicates the step of inserting or pressing the device onto the vial, likely for medication preparation or injection setup.*

FDA Label Image

Vial Ifu-figure F (Image 09)

An instructional illustration showing a hand holding a pen injector device above a vial, with an arrow pointing downward indicating to insert the needle or draw medication from the vial. This likely relates to the preparation or use of the TRESIBA pen injector.*

FDA Label Image

Vial Ifu-figure G (Image 10)

Illustration showing a hand holding a pen-like injector device inverted above a syringe, indicating the action to tap or flick the device to remove air bubbles or ensure proper priming before injection. Another hand is holding the syringe base.*

FDA Label Image

Vial Ifu-figure H (Image 11)

Instructional diagram showing how to prepare a dose by pulling on the dose knob of a pen injector device. The image includes a close-up inset of the pen's dial indicating dose selection, and an arrow pointing upwards demonstrating the pulling motion required on the dose knob.*

FDA Label Image

Vial Ifu-figure I (Image 12)

An instructional illustration showing a hand holding and preparing a TRESIBA insulin injection pen for use by attaching or removing the needle cap. The graphic depicts a step in the injection process with an arrow indicating movement.*

FDA Label Image

Vial Ifu-figure J (Image 13)

An anatomical illustration showing the front and back views of a human figure with highlighted areas on the thighs and abdomen. This diagram typically indicates recommended injection sites.*

FDA Label Image

Vial Ifu-figure K (Image 14)

An instructional illustration showing a hand holding a dropper above a finger, with an arrow indicating the dropper is dispensing liquid onto the fingertip. This likely demonstrates how to use the product or check blood glucose levels.*

FDA Label Image

Vial Ifu-figure L (Image 15)

An instructional illustration showing a hand holding a syringe or pen device injecting into a forearm. An arrow indicates the direction of the injection into the skin.*

FDA Label Image

Figure A: Novofine Needle Components (Image 16)

An instructional diagram labeled NovoFine illustrating the components of a needle assembly. It shows the outer needle cap, inner needle cap, needle, and a paper tab, each clearly labeled and visually separated in sequence from left to right.*

FDA Label Image

Figure A: Novotwist Needle Components (Image 17)

An instructional diagram showing four components of a NovoTwist needle system used for injections: the outer needle cap, the inner needle cap, the needle itself, and a paper tab. Each part is labeled clearly to guide users on assembly or handling.*

FDA Label Image

Fig. A (Image 18)

An instructional diagram of a TRESIBA FlexTouch insulin injection pen by A-S Medication Solutions. The diagram labels parts including the pen cap, insulin scale, insulin window, dose counter, dose selector, dose pointer, and dose button.*

FDA Label Image

100 U/ml Ifu (Figure B)

An instructional illustration showing hands preparing a TRESIBA insulin pen for injection by removing a yellow cap from the pen's needle area (Figure B). It depicts the step of taking off the outer needle cap prior to use.*

FDA Label Image

100 U/ml Ifu (Figure C)

An instructional diagram labeled as Figure C illustrating how to hold the TRESIBA insulin pen with the cap removed, focusing on the pen's dosing window and tip region. It is a simplified graphic showing hand placement on the pen.*

FDA Label Image

100 U/ml Ifu (Figure D)

An instructional illustration labeled 'Figure D' showing two panels side by side. Each panel demonstrates the correct way to remove a device labeled 'NovoFine' and 'NovoTwist' by gripping and pulling in the direction indicated by an arrow. The images guide users on how to detach these components properly.*

FDA Label Image

100 U/ml Ifu (Figure E)

An instructional illustration showing the NovoFine® needle and NovoTwist® mechanism. The diagram depicts how to attach or use the needle with a twisting motion on an injection device.*

FDA Label Image

100 U/ml Ifu (Figure F)

An instructional diagram showing two steps to connect a syringe to an injection pen device. The first part labeled 'NovoFine' shows inserting a needle onto the syringe. The second part labeled 'NovoTwist' illustrates twisting the attached needle onto the injection pen. The image uses arrows to indicate the actions.*

FDA Label Image

100 U/ml Ifu (Figure G)

Instructional illustration showing how to use components labeled NovoFine and NovoTwist. The images depict a step where a needle is attached to a pen device, indicated by arrows guiding the connection process.*

FDA Label Image

100 U/ml Ifu (Figure H)

An instructional illustration showing a person selecting the dose on a TRESIBA insulin device. The dose window displays the number 2, indicating 2 units selected, with an arrow pointing upward to the dial mechanism being adjusted by the fingers.*

FDA Label Image

100 U/ml Ifu (Figure I)

An instructional illustration showing a hand holding a TRESIBA insulin pen, emphasizing the pen tip. This figure likely demonstrates part of the injection preparation or use procedure for the TRESIBA injectable.*

FDA Label Image

100 U/ml Ifu (Figure J)

An instructional illustration showing a hand holding a TRESIBA insulin pen, with an arrow pointing upward, indicating a step in the preparation or injection process. A close-up view highlights the pen's needle end, emphasizing proper handling.*

FDA Label Image

100 U/ml Ifu (Figure K)

An instructional diagram illustrating the selection of insulin dosage units on a TRESIBA insulin pen. It shows a close-up of the pen's dose selector with arrows indicating the turning mechanism, alongside examples displaying a 5-unit dose and a 24-unit dose selected on the dose window.*

FDA Label Image

100 U/ml Ifu (Figure L)

An illustration of a pen-style injection device commonly used for injectable medications. It shows a transparent window with dose markings and an indicator approximately at the 200-unit level. The pen is primarily white and green with a gray dose adjustment knob at the bottom. The image includes the text 'Example Approx. 200 units left' highlighting the dose indicator level.*

FDA Label Image

100 U/ml Ifu (Figure M)

An instructional anatomical diagram showing front and back views of a human figure highlighting potential insulin injection sites including the abdomen, outer thigh, and upper buttocks.*

FDA Label Image

100 U/ml Ifu (Figure N)

Illustration showing a hand holding a TRESIBA insulin pen with an arrow pointing downward, demonstrating the proper orientation for use or an injection step.*

FDA Label Image

100 U/ml Ifu (Figure O)

Illustration showing a hand holding a pen-type injector with an arrow pointing downward, indicating a step in the injection process. A magnified inset shows the injector needle with a number 0.3, likely representing the dose or injection depth. This diagram likely demonstrates how to hold and use the TRESIBA injection device properly.*

FDA Label Image

100 U/ml Ifu (Figure P)

An instructional illustration showing a hand holding a test tube or vial, with the other hand positioned underneath as if to catch drops. A speech bubble instructs to count slowly from 1 to 6, indicating a timing or counting step in a procedure.*

FDA Label Image

100 U/ml Ifu (Figure Q)

An instructional illustration showing a pen-type device with an upward pointing arrow above it, indicating removal or lifting of the cap or a component from the pen.*

FDA Label Image

100 U/ml Ifu (Figure R)

An instructional illustration depicting the use of NovoFine and NovoTwist devices. The image shows how to align and insert a needle by following the directional arrows for proper attachment or removal, with a focus on the needle positioning relative to the injection pen.*

FDA Label Image

100 U/ml Ifu (Figure S)

An instructional diagram showing the assembly of a needle cap and a syringe or injection pen. The image includes arrows indicating the direction to push or attach the needle cap onto the device. This figure is labeled as (Figure S).*

FDA Label Image

100 U/ml Ifu (Figure T)

An instructional illustration showing a close-up of hands holding and twisting a component, likely part of a pen or injector device, with an arrow indicating a twisting motion. The figure is labeled 'Figure T' and appears to demonstrate part of the usage or preparation process for the TRESIBA product.*

FDA Label Image

Qr Code 100 Units/ml (Image 38)

FDA Label Image

U200 Figure A (Image 39)

An illustration diagram of the TRESIBA FlexTouch insulin pen device by A-S Medication Solutions. The diagram labels the pen cap, insulin scale, insulin window, dose counter, dose selector, and the branded label area on the pen.*

FDA Label Image

Figure A: Novofine Needle Components (Image 40)

An instructional illustration showing the components of a NovoFine needle assembly. From left to right, it displays the outer needle cap, inner needle cap, needle, and paper tab, each separately labeled and depicted in a simplified graphic form.*

FDA Label Image

Figure A: Novotwist Needle Components (Image 41)

An instructional diagram labeled NovoTwist showing components of a needle assembly: outer needle cap, inner needle cap, needle, and paper tab, presented in a linear sequence from left to right.*

FDA Label Image

200 U/ml Ifu Figure B (Image 43)

An instructional illustration showing the action of removing or detaching a green-colored cap or cover from a device held in two hands. The image is labeled as Figure B, suggesting it is part of a step-by-step guide related to the TRESIBA product usage or preparation.*

FDA Label Image

200 U/ml Ifu Figure C (Image 44)

An instructional illustration showing a close-up of a TRESIBA injection device, highlighting the needle cap removal step (Figure C). The image focuses on the pen needle portion of the device, aiding patient use guidance.*

FDA Label Image

200 U/ml Ifu Figure D (Image 45)

An instructional illustration showing the use of NovoFine and NovoTwist pen needles. The image demonstrates removing the cap by pulling and twisting, indicated by arrows, with close-up views of fingers gripping the needle cap.*

FDA Label Image

200 U/ml Ifu Figure E (Image 46)

An instructional illustration showing two steps labeled 'NovoFine' and 'NovoTwist.' The image demonstrates how to handle a green pen-shaped device by first pulling a cap off and then twisting a cover. This is likely part of a device preparation or injection process.*

FDA Label Image

200 U/ml Ifu Figure F (Image 47)

Instructional illustration showing how to connect a NovoFine needle to a NovoTwist insulin pen. Two sequential close-up images depict aligning and attaching the needle securely by twisting it onto the pen for use with TRESIBA insulin.*

FDA Label Image

200 U/ml Ifu Figure G (Image 48)

An instructional illustration showing two steps: first, a NovoFine needle is being attached to an insulin pen; second, a NovoTwist needle cap is being removed by twisting off the outer covering. The diagram is labeled as Figure G and demonstrates proper needle preparation for injection.*

FDA Label Image

200 U/ml Ifu Figure H (Image 49)

Illustration showing hands adjusting a dosing device for TRESIBA insulin, indicating the selection of 2 units on the dose counter. The image demonstrates how to set the dose by turning the dial on the pen injector.*

FDA Label Image

Figure 3 (Image 52)

A line graph showing the cumulative percentage of subjects with a first event over 30 months. The horizontal axis represents time to first event in months from 0 to 30, and the vertical axis shows the percentage of subjects with an event from 0% to 10%. Two groups are compared: one labeled IDeg (solid line) and the other IGlAr (dashed line). The graph includes a hazard ratio with a 95% confidence interval: 0.91 [0.78; 1.06]. Numbers of subjects at risk at various times are listed below the timeline.*

FDA Label Image

200 U/ml Ifu Figure I (Image 53)

Illustration depicting a hand pressing down on the top of a TRESIBA pen injector, showing the mechanism to release the medication inside the pen. The image emphasizes finger placement and action on the pen device, relevant to the use instructions for TRESIBA by A-S Medication Solutions.*

FDA Label Image

200 U/ml Ifu Figure J (Image 54)

An instructional illustration showing a hand holding a TRESIBA injection pen, presumably to demonstrate operation steps. The pen has a blue lower section and a clear upper section for the insulin cartridge. An arrow pointing upward indicates upward movement or removal action.*

FDA Label Image

200 U/ml Ifu Figure K (Image 55)

Illustration showing how to set the dose on a TRESIBA insulin pen. It depicts a hand adjusting the dose selector with examples of selecting 6 units and 24 units. Arrows indicate the rotation mechanism to choose the desired insulin units.*

FDA Label Image

200 U/ml Ifu Figure L (Image 56)

An instructional illustration showing a syringe filled to approximately 400 units. The syringe body features graduated markings indicating dosage measurements. The needle and the plunger are visible, with the plunger positioned to show the volume of liquid inside. The illustration includes blue text noting 'Example Approx. 400 units left.'*

FDA Label Image

200 U/ml Ifu Figure M (Image 57)

Illustration showing a front and back view of a human body with shaded areas indicating recommended injection sites on the thighs, abdomen, and upper buttocks, likely related to TRESIBA administration.*

FDA Label Image

200 U/ml Ifu Figure N (Image 58)

An instructional illustration showing a hand holding an injectable pen device with an arrow pointing downward, likely indicating a step in the injection procedure for TRESIBA by A-S Medication Solutions.*

FDA Label Image

200 U/ml Ifu Figure O (Image 59)

Illustration demonstrating how to insert a cartridge into a device, showing a hand holding the device and an arrow indicating the cartridge insertion direction.*

FDA Label Image

200 U/ml Ifu Figure P (Image 60)

An instructional illustration showing a hand holding an insulin pen vertically with the thumb on top, counting slowly from 1 to 6 as indicated in a speech bubble. The figure is labeled as 'Figure P', demonstrating the technique for preparing or administering a dose, related to the product TRESIBA by A-S Medication Solutions.*

FDA Label Image

200 U/ml Ifu Figure Q (Image 61)

An instructional illustration showing part of a medical device pen, with an arrow pointing upward, likely indicating the direction to pull or remove a component. The pen appears to be pre-filled, with visible internal parts in green and white.*

FDA Label Image

200 U/ml Ifu Figure R (Image 62)

An instructional diagram illustrating the use of NovoFine and NovoTwist needles. The image shows rotating and pulling actions on a needle cap attached to a green pen device, demonstrating steps for needle removal or attachment.*

FDA Label Image

200 U/ml Ifu Figure S (Image 63)

An instructional diagram showing a close-up of a cap being removed from a pen needle, illustrating the proper step for preparing an injection pen device, relevant to TRESIBA insulin delivery.*

FDA Label Image

200 U/ml Ifu Figure T (Image 64)

An instructional diagram showing hands pulling apart a component, likely related to the TRESIBA product pen or injector, demonstrating a step in preparing the device for use. The image focuses on manual interaction with a small cylindrical part.*

FDA Label Image

Qr Code 200 Units/ml Ifu (Image 65)

FDA Label Image

Label Image (Lbl500907077)

Label for TRESIBA (insulin degludec) injection U-100, a 100 units per milliliter insulin product by A-S Medication Solutions. The label includes dosing instructions, storage conditions specifying refrigeration at 36 to 46 degrees Fahrenheit and avoiding freezing or direct light, and notes the package contains five 3 milliliter prefilled pens. The NDC number 50090-7077-0 is displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.